Dr. Kian-Huat Lim, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Expert in Pancreatic Cancer
Studies Rectal Cancer
24 reported clinical trials
54 drugs studied
About Kian-Huat Lim, M.D., Ph.D.
Education:
- Earned MD from National Taiwan University College of Medicine in 1999.
- Completed Molecular Cancer Biology Program at Duke University in 2006.
- Participated in the Physician-Scientist Training Program at Washington University School of Medicine in 2010.
Experience:
- Serves as an Associate Professor of Medicine at Washington University School of Medicine.
- Holds Board Certifications in Internal Medicine and Medical Oncology.
- Specializes in gastrointestinal oncology, focusing on colorectal, pancreatic, and hepatobiliary cancers.
- Research interests include exploring the link between inflammation and cancer progression and developing new treatments to improve chemotherapy and radiation responses.
- Affiliated with Barnes-Jewish Hospital and Barnes-Jewish West County Hospital.
Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Rectal Cancer
Stage III
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Kian-Huat Lim, M.D., Ph.D. is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Genetic Results Return
for Cancer Patients
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.
Recruiting1 award N/A
More about Kian-Huat Lim, M.D., Ph.D.
Clinical Trial Related7 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Kian-Huat Lim, M.D., Ph.D. has experience with
- Gemcitabine
- Nab-paclitaxel
- Nivolumab
- Defactinib
- Oxaliplatin
- Leucovorin
Breakdown of trials Kian-Huat Lim, M.D., Ph.D. has run
Pancreatic Cancer
Rectal Cancer
Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kian-Huat Lim, M.D., Ph.D. specialize in?
Kian-Huat Lim, M.D., Ph.D. focuses on Pancreatic Cancer and Rectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kian-Huat Lim, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Kian-Huat Lim, M.D., Ph.D. is currently recruiting for 7 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kian-Huat Lim, M.D., Ph.D. has studied deeply?
Yes, Kian-Huat Lim, M.D., Ph.D. has studied treatments such as Gemcitabine, Nab-paclitaxel, Nivolumab.
What is the best way to schedule an appointment with Kian-Huat Lim, M.D., Ph.D.?
Apply for one of the trials that Kian-Huat Lim, M.D., Ph.D. is conducting.
What is the office address of Kian-Huat Lim, M.D., Ph.D.?
The office of Kian-Huat Lim, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.